BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 2596314)

  • 1. The role of gastric and duodenal pH in the cysteamine-induced duodenal ulcer in the rat.
    Kusterer K; Rohr G; Herrmann W; Piplack C; Schwedes U; Usadel KH; Szabo S
    Acta Physiol Hung; 1989; 73(2-3):247-50. PubMed ID: 2596314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of local secretory and motility changes in the pathogenesis of experimental duodenal ulcer.
    Szabo S; Pihan G; Gallagher GT; Brown A
    Scand J Gastroenterol Suppl; 1984; 92():106-11. PubMed ID: 6588493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dopamine-related drugs on duodenal ulcer induced by cysteamine or propionitrile: prevention and aggravation may not be mediated by gastrointestinal secretory changes in the rat.
    Gallagher G; Brown A; Szabo S
    J Pharmacol Exp Ther; 1987 Mar; 240(3):883-9. PubMed ID: 3559980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diversion of bile and pancreatic secretion in the rat and its effect on cysteamine-induced duodenal and peptic ulcer development under maximal acid secretion.
    Clémençon GH; Fehr HF; Finger J
    Scand J Gastroenterol Suppl; 1984; 92():112-5. PubMed ID: 6588494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteamine-induced duodenal ulcer is not site-specific: effect of local modulating factors.
    Adler RS; Nafradi J; Szabo S
    J Exp Pathol; 1985; 2(2):111-22. PubMed ID: 3842391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of verapamil on cysteamine-induced duodenal ulcer in the rat.
    Lee CK; Yim DS; Kim WH
    J Korean Med Sci; 1987 Dec; 2(4):247-53. PubMed ID: 3268182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidermal growth factor inhibits cysteamine-induced duodenal ulcers.
    Kirkegaard P; Olsen PS; Poulsen SS; Nexø E
    Gastroenterology; 1983 Dec; 85(6):1277-83. PubMed ID: 6605273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of cysteamine on the Brunner gland secretion in the rat.
    Kirkegaard P; Poulsen SS; Halse C; Loud FB; Skov Olsen P; Christiansen J
    Scand J Gastroenterol; 1981; 16(1):93-6. PubMed ID: 7233083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory changes associated with chemically-induced duodenal ulceration: simultaneous measurements of acid, pepsin, base and pancreatic enzymes in rats with chronic gastric fistula.
    Gallagher GT; Szabo S
    Digestion; 1984; 29(2):73-84. PubMed ID: 6203801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenic aspects of duodenal ulcers by cysteamine. Role of the Brunner glands].
    Laudanno OM; Bedini OA; Cesolari JA; San Miguel P
    Acta Gastroenterol Latinoam; 1988; 18(3):187-94. PubMed ID: 3270301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteamine-induced duodenal ulcer and acid secretion in the rat.
    Kirkegaard P; Poulsen SS; Loud FB; Halse C; Christiansen J
    Scand J Gastroenterol; 1980; 15(5):621-4. PubMed ID: 7444368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tyrosine administration on duodenal ulcer induced by cysteamine in the rat.
    Oishi T; Szabo S
    J Pharmacol Exp Ther; 1987 Mar; 240(3):879-82. PubMed ID: 3559979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of centrally administered oxytocin on gastric and duodenal ulcers in rats.
    Asad M; Shewade DG; Koumaravelou K; Abraham BK; Vasu S; Ramaswamy S
    Acta Pharmacol Sin; 2001 Jun; 22(6):488-92. PubMed ID: 11747752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duodenal ulcerogens cysteamine and propionitrile decrease duodenal neutralization of acid in the rat.
    Adler RS; Gallagher GT; Szabo S
    Dig Dis Sci; 1983 Aug; 28(8):716-23. PubMed ID: 6872804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel small molecule CFTR inhibitor attenuates HCO3- secretion and duodenal ulcer formation in rats.
    Akiba Y; Jung M; Ouk S; Kaunitz JD
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G753-9. PubMed ID: 15905414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 5-acetylspiro[benzofuran-2(3H),1'-cyclopropan]-3-one, a new anti-ulcer agent, on experimental acute and chronic ulcers.
    Inatomi N; Hirata T; Inada I; Satoh H; Sino A; Maki Y
    Arzneimittelforschung; 1985; 35(10):1553-9. PubMed ID: 4074415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of duodenal ulcer. Gastric hyperacidity caused by propionitrile and cysteamine in rats.
    Szabo S; Reynolds ES; Lictenberger LM; Haith LR; Dzau VJ
    Res Commun Chem Pathol Pharmacol; 1977 Feb; 16(2):311-23. PubMed ID: 847287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary and pancreatic secretions influence experimental duodenal ulcer without affecting gastric secretion in the rat.
    Pihan G; Gallagher GT; Szabo S
    Dig Dis Sci; 1985 Mar; 30(3):240-6. PubMed ID: 3918841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective decrease of duodenal phosphoprotein phosphatase activity is a general property of duodenal ulcerogens.
    Japundzić I; Japundzić M; Szabó S
    Acta Physiol Hung; 1989; 73(2-3):225-32. PubMed ID: 2556888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of different prostaglandins on cysteamine-induced duodenal ulcer in the rat.
    Náfrádi J; Bálint GA; Varró V
    Acta Physiol Hung; 1984; 64(3-4):339-41. PubMed ID: 6397967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.